Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
Wagenlehner FM, Kinzig-Schippers M, Tischmeyer U, Wagenlehner C, Sörgel F, Dalhoff A, Naber KG. Wagenlehner FM, et al. Among authors: wagenlehner c. Int J Antimicrob Agents. 2006 Jan;27(1):7-14. doi: 10.1016/j.ijantimicag.2005.09.014. Epub 2005 Dec 15. Int J Antimicrob Agents. 2006. PMID: 16343856 Clinical Trial.
Urinary concentrations and antibacterial activities of nitroxoline at 250 milligrams versus trimethoprim at 200 milligrams against uropathogens in healthy volunteers.
Wagenlehner FM, Münch F, Pilatz A, Bärmann B, Weidner W, Wagenlehner CM, Straubinger M, Blenk H, Pfister W, Kresken M, Naber KG. Wagenlehner FM, et al. Among authors: wagenlehner cm. Antimicrob Agents Chemother. 2014;58(2):713-21. doi: 10.1128/AAC.02147-13. Epub 2013 Nov 11. Antimicrob Agents Chemother. 2014. PMID: 24217699 Free PMC article. Clinical Trial.
Urinary bactericidal activity of extended-release ciprofloxacin (1,000 milligrams) versus levofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.
Wagenlehner FM, Kinzig-Schippers M, Tischmeyer U, Wagenlehner C, Sörgel F, Naber KG. Wagenlehner FM, et al. Among authors: wagenlehner c. Antimicrob Agents Chemother. 2006 Nov;50(11):3947-9. doi: 10.1128/AAC.00477-06. Epub 2006 Sep 18. Antimicrob Agents Chemother. 2006. PMID: 16982785 Free PMC article. Clinical Trial.
Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate.
Wagenlehner FM, Wagenlehner C, Schinzel S, Naber KG; Working Group "Urological Infections" of German Society of Urology. Wagenlehner FM, et al. Among authors: wagenlehner c. Eur Urol. 2005 Apr;47(4):549-56. doi: 10.1016/j.eururo.2005.01.004. Epub 2005 Jan 18. Eur Urol. 2005. PMID: 15774257 Clinical Trial.
Anti-infective treatment of bacterial urinary tract infections.
Wagenlehner FM, Pilatz A, Naber KG, Perletti G, Wagenlehner CM, Weidner W. Wagenlehner FM, et al. Among authors: wagenlehner cm. Curr Med Chem. 2008;15(14):1412-27. doi: 10.2174/092986708784567699. Curr Med Chem. 2008. PMID: 18537619 Review.
12 results